AVIRAtea Pharmaceuticals, Inc.

$484M

Q1 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$4,000

Operating Income

-$4M

Net Income

-$4M

EPS (Diluted)

$-0.08

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$189,000

Balance Sheet

Total Assets

$18M

Total Liabilities

$2M

Stockholders' Equity

$16M

Cash & Equivalents

$17M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$4,000	$0	—
Operating Income	-$4M	-$2M	-70.5%
Net Income	-$4M	-$2M	-81.9%

AVIR Q1 2020 Earnings — Atea Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena